Dr. Durrant is an entrepreneur, board member, C-level executive, former big pharma executive, and an MD by original training. He is Chairman and CEO of Humanigen, a Nasdaq-listed public company developing biologics for a range of serious and life-threatening conditions. His specialty is both startups and turnarounds, including brands and business units as well as companies. He has served as board chairman, and lead independent director for both private and public companies. He has four successful exits. Additionally, he served as head of infectious disease at Johnson & Johnson and other blue-chip companies. In addition, he has raised several hundred million dollars from a variety of sources and has been an executive at several blue-chip big pharma companies, and held business unit P+L and staff roles, both in the US and globally. He is a founding director of a private nanotech and a board member of a private gene therapy company.